info.eurekaplatform.orgEureka – A Digital Research

Platform About Eureka About Team Jobs Privacy Policy Contact For Researchers Our Services Publications Frequently Asked Questions Get in Touch For Participants Browse Studies Frequently Asked Questions Discoveries We build online medical research studies Eureka is a non-profit resource out of the University of California San Francisco. We make it easy to answer surveys and contribute data from apps, devices, and other novel sources for research. It’s never been easier to make an impact! Browse Studies → Our Services → FOR RESEARCHERS We build many types of studies Intervention studies Randomize your participants to different study arms. Rare disease studies Overcome geographic barriers to participation with an online study. Long-term registries Develop a longitudinal well-characterized cohort. Pilot studies Get your idea in front of participants quickly. Ecological Momentary Assessment Trigger surveys at the right time. Device studies Test a new device or collect novel data from our available integrations. Multi-center trials Coordinate study management. Collect data all in one place. FOR RESEARCHERS An all-in-one platform 1 Participant Enrollment We can customize eligibility surveys, digital consent, randomization, and more to allow your participants to easily enroll in your study. 2 Data Collection and Participant Experience Allow your participants to easily answer surveys, connect devices, and link medical records. Your study design can be customized and participant experience can be personalized. Notify participants of available activities with reminder messages. Our expert team has years of experience to help you optimize participation. 3 Study Management Easily view the progress of your participants through your study, add new sites, and manage consent documents on our admin panel. Specify admin team roles across sites secured by two-factor authentication. 4 Data Storage and Reports All data is stored in our secure, HIPAA-compliant cloud storage. Download clean data in universal formats like CSV with your data ready for analysis. Explore our platform See our studies Health eHeart Health eHeart is an ambitious study to end Heart Disease. It only takes a few minutes to make a big difference. Anyone can join — whether you have Heart Disease or not. Learn More COVID-19 Citizen Science A large study tracking COVID-19 infections and risk factors. Anyone 18 years old or older can participate, even if you are healthy. Learn More eNET Doctors at UCSF are collecting information to learn about quality of life, symptoms, lifestyle, and well-being for patients with neuroendocrine tumors. This study invites people with neuroendocrine tumors to join. Learn More See all studies Our Recent Writings MCNAIR Welcome, University of Michigan! ¡Bienvenido Universidad de Michigan! Welcome to the MCNAIR Study, University of Michigan! On February 12, 2024, Michigan enrolled their… BEAT AFib What are PACs? Read our updates about the progress we are making in this study! BEAT AFib What’s New in the BEAT-AFib Study in December 2023? Read more about the new BEAT-AFib resources and app features. Read More Publications Predictors of incident viral symptoms ascertained in the era of COVID-19. Gregory M. Marcus et al. Gregory M. Marcus, Jeffrey E. Olgin, Noah D. Peyser, Eric Vittinghoff, Vivian Yang, Sean Joyce, Robert Avram, Geoffrey H. Tison, David Wen, Xochitl Butcher, Helena Eitel, Mark J. Pletcher. PLoS One. 2021. In the absence of universal testing, effective therapies, or vaccines, identifying risk factors for viral infection, particularly readily modifiable exposures and behaviors, is required to identify effective strategies against viral infection and transmission… HLA-B*15:01 is associated with asymptomatic SARS-CoV-2 infection. Danillo G. Augusto et al. Danillo G. Augusto, Tasneem Yusufali, Noah D. Peyser, Xochitl Butcher, Gregory M. Marcus, Jeffrey E. Olgin, Mark J. Pletcher, Martin Maiers, Jill A. Hollenbach. medRxiv. 2021. Background: Evidence has shown that a large proportion of SARS-CoV-2 infected individuals do not experience symptomatic disease. Owing to its critical role in immune response, we hypothesized that variation in the human leukocyte antigen (HLA) loci may underly asymptomatic infection… Factors Associated With Access to and Timing of Coronavirus Testing Among US Adults After Onset of Febrile Illness. Mark J. Pletcher et al. Mark J. Pletcher, Jeffrey E. Olgin, Noah D. Peyser, Madelaine Faulkner Modrow, Feng Lin, Jeffrey Martin, Thomas Carton, Alexis L. Beatty, Eric Vittinghoff, Gregory M. Marcus. JAMA Netw Open. 2021. Question: How often do persons with new febrile illness access coronavirus testing and receive a test result within 7 days of illness onset? See all publications Home About Platform Team FAQ Contact coordinator@eurekaplatform.org © 2024 Eureka. About Eureka About Team Jobs Privacy Policy Contact For Researchers Our Services Publications Frequently Asked Questions Get in Touch For Participants Browse Studies Frequently Asked...